![David Lawrence Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Lawrence Lee
Direktor/Vorstandsmitglied bei Communications Networking Services (UK) Ltd.
Profil
David Lawrence Lee has held director positions at Communications Networking Services (UK) Ltd.
and Pharmaorigin A.
Aktive Positionen von David Lawrence Lee
Unternehmen | Position | Beginn |
---|---|---|
Communications Networking Services (UK) Ltd.
![]() Communications Networking Services (UK) Ltd. Specialty TelecommunicationsCommunications Communications Networking Services (UK) Ltd. is based in London, UK. Part of BT Group Plc, Communications Networking Services (UK) Ltd. is a British company that provides telecommunication services. | Direktor/Vorstandsmitglied | - |
Pharmaorigin A/S
![]() Pharmaorigin A/S Pharmaceuticals: MajorHealth Technology Pharmaorigin ApS is a holding company that provides medical treatment. It offers medication for prevention of bleeding in surgical interventions or invasive procedures in patients with acquired hemophilia. The company was founded by Lars Heslet on November 14, 2005 and is headquartered in H?rsholm, Denmark. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Communications Networking Services (UK) Ltd.
![]() Communications Networking Services (UK) Ltd. Specialty TelecommunicationsCommunications Communications Networking Services (UK) Ltd. is based in London, UK. Part of BT Group Plc, Communications Networking Services (UK) Ltd. is a British company that provides telecommunication services. | Communications |
Pharmaorigin A/S
![]() Pharmaorigin A/S Pharmaceuticals: MajorHealth Technology Pharmaorigin ApS is a holding company that provides medical treatment. It offers medication for prevention of bleeding in surgical interventions or invasive procedures in patients with acquired hemophilia. The company was founded by Lars Heslet on November 14, 2005 and is headquartered in H?rsholm, Denmark. | Health Technology |